Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on May 5, 2025
DrEO Clinic Named Best Hair Transplant Clinic in Mexico for 2025, Leading the Way in Affordable Medical Tourism
GlobeNewswire
·
May 5, 2025
Mexico City, Mexico, May 05, 2025 (GLOBE NEWSWIRE) -- DrEO Clinic has been recognized as the best hair transplant clinic in Mexico for 2025, reinforcing its position at the forefront of hair restoration excellence. The announcement follows endorsements …
Global Extended Release Drugs Market Set to Reach CAGR of 11% through 2032 | FMI
EIN Presswire
·
May 5, 2025
Extended Release Drugs Market sees rising demand due to improved patient compliance, steady dosing, and reduced side effects. NEWARK, DE, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- The global extended release drugs market is witnessing remarkable …
Global Small Bowel Enteroscope Market Set for Robust Growth, Expected to Surpass 8% to 9% CAGR by 2032
EIN Presswire
·
May 5, 2025
Rising GI disorders and advanced endoscopy tech fuel growth in the small bowel enteroscopes market globally. NEWARK, DE, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- The global small bowel enteroscope market is poised for a decade of strong and …
Robert Olsen Receives Individual Achievement Award from the Healthcare Financial Management Association
GlobeNewswire
·
May 5, 2025
NASHVILLE, Tenn., May 05, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today presented Robert Olsen with the 2025 Frederick C. Morgan Individual Achievement Award, honoring career-long contributions to HFMA and to the …
Prostate Cancer Types Market Set for Robust Growth Through 2034, Driven by Advances in Targeted Therapies and Biomarker | DelveInsight
GlobeNewswire
·
May 5, 2025
New York, USA, May 05, 2025 (GLOBE NEWSWIRE) -- Prostate Cancer Types Market Set for Robust Growth Through 2034, Driven by Advances in Targeted Therapies and Biomarker | DelveInsight The prostate cancer market is expected to witness significant growth …
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program
GlobeNewswire
·
May 5, 2025
ZURICH, SWITZERLAND, May 05, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ: VACH, "Voyager"), announced today a co- …
OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab
GlobeNewswire
·
May 5, 2025
OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab Lusvertikimab well tolerated over the 24-week additional treatment period. Oral presentation at DDW 2025 of clinical data from …
OSE Immunotherapeutics annonce que plus de 90% des patients répondeurs ont maintenu une rémission symptomatique pendant la période d’extension sous Lusvertikimab
GlobeNewswire
·
May 5, 2025
OSE Immunotherapeutics annonce que plus de 90 % des patients répondeurs ont maintenu une rémission symptomatique pendant la période d’extension sous Lusvertikimab Bonne tolérance de Lusvertikimab pendant les 24 semaines supplémentaires de traitement. …
MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report
GlobeNewswire
·
May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell …
How individuals grasp an object may offer simpler diagnosis for autism spectrum disorder
GlobeNewswire
·
May 5, 2025
Toronto, May 05, 2025 (GLOBE NEWSWIRE) -- Getting a timely diagnosis of autism spectrum disorder is a major challenge, but new research out of York University shows that how young adults, and potentially children, grasp objects could offer a simpler way to …
AB Science will present new data from masitinib clinical program in ALS in two presentations at the 2025 ENCALS Annual Meeting
GlobeNewswire
·
May 5, 2025
PRESS RELEASE AB SCIENCE TO PRESENT NEW DATA FROM MASITINIB CLINICAL PROGRAM IN AMYOTROPHIC LATERAL SCLEROSIS IN TWO PRESENTATIONS AT THE 2025 ENCALS ANNUAL MEETING MASITINIB REDUCES SERUM NEUROFILAMENT LIGHT CHAIN (NFL) LEVELS, SUGGESTING THAT IT HAS …
AB Science présentera lors de la réunion annuelle de l’ENCALS en 2025 de nouvelles données issues du programme de développement clinique du masitinib dans la SLA
GlobeNewswire
·
May 5, 2025
COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTERA LORS DE LA RÉUNION ANNUELLE DE L'ENCALS EN 2025 DE NOUVELLES DONNÉES ISSUES DU PROGRAMME DE DEVELOPPEMENT CLINIQUE DU MASITINIB DANS LA SCLÉROSE LATÉRALE AMYOTROPHIQUE LE MASITINIB RÉDUIT LA CONCENTRATION SERIQUE …
Arialief Reviews (CRITICAL INVESTIGATION) What Doctors Say About Arialief's Safety And Complaints!
GlobeNewswire
·
May 5, 2025
ALBANY, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- Arialief is a thoughtfully designed natural nerve pain relief supplement that can address the root issues behind various symptoms associated with neuropathy. It is backed up by solid research and combines …
Arialief Side Effects Investigated: Review the User Complaints, Top Benefits & Ingredients List Before Buy!
GlobeNewswire
·
May 5, 2025
ALBANY, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- If you’re reading this, chances are you, or someone close to you, is dealing with the frustrating, often exhausting symptoms of nerve pain. Whether it’s tingling in your feet, burning sensations in your hands, …
MicroRNAs Research Initiative in Glioblastoma Stem Cells Awarded $85K by Brain Cancer Canada
GlobeNewswire
·
May 5, 2025
TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Brain Cancer Canada is pleased to announce a $85,000 grant for a cutting-edge research initiative led by Dr. Leonardo Salmena at the University of Toronto. The project, titled “Exploring microRNA as Targets for …
Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)
GlobeNewswire
·
May 5, 2025
ORION OYJ PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE 5.5.2025 KLO 17.00 Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n …
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
GlobeNewswire
·
May 5, 2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 5 May 2025 at 17:00 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has …
Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference
GlobeNewswire
·
May 5, 2025
BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
CareSource and Lakeland Care, Inc. pursue affiliation to enhance long-term services and supports offerings across Wisconsin
GlobeNewswire
·
May 5, 2025
DAYTON, Ohio and FOND du LAC, Wis., May 05, 2025 (GLOBE NEWSWIRE) -- CareSource, a nationally recognized nonprofit managed care organization, and Lakeland Care, Inc., a leading Wisconsin-based managed care provider, have announced their intent to pursue an …
LainaHealth Launches Clinician + WebAI Care Model to Redefine Physical Therapy Access and Affordability
GlobeNewswire
·
May 5, 2025
Columbus, OH, May 05, 2025 (GLOBE NEWSWIRE) -- LainaHealth, formerly IncludeHealth, announced today the launch of its transformative virtual care model that pairs licensed physical therapists with Laina, a proprietary WebAI assistant, to significantly …